Market Access
Medicines pricing, UK £20 notes with various pills

Buyer’s remorse: The UK’s VPAG

With the ABPI wanting to change the scheme just over a year into its five-year term, it seems that they have buyer’s remorse.

Sales & Marketing

Digital

Market Access

Market Access
Medicines pricing, UK £20 notes with various pills

Buyer’s remorse: The UK’s VPAG

With the ABPI wanting to change the scheme just over a year into its five-year term, it seems that they have buyer’s remorse.

Editor's Picks

  1. Merck agrees $3.9 billion takeover of SpringWorks
  2. Organised medicines trafficking, 12 arrests made in MHRA crackdown
  3. NEJM responds to claims of bias from Justice Department
  4. US is planning $500m project on 'universal vaccines;' WSJ
  5. Lilly hit as PBM drops Zepbound, but retains Wegovy

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more